Gelteq Restricted (NASDAQ: GELS) is a healthcare firm specializing within the improvement and manufacturing of edible gel merchandise, with a deal with areas like prescription drugs, nutraceuticals, pet care, and sports activities diet. The corporate’s gel-based oral drug supply system is designed to boost the administration of medicines and vitamins, addressing points like dysphagia and capsule fatigue.
In an e mail dialog with AlphaStreet, Nathan Givoni, Gelteq’s CEO and co-founder, and Simon Szewach, government chairman and co-founder, mentioned numerous elements of the enterprise.
When founding Gelteq, what market wants have been you aiming to satisfy together with your gel-based oral drug supply system?
The gel-based oral drug supply system was developed initially to help in making it simpler for the aged to devour bigger volumes of their required vitamins in a concentrated kind, that was additionally each simpler to swallow and tasted higher.
Gelteq has been repeatedly evolving to develop our purposes and audiences. Our customizable expertise can cater to these with dysphagia, youngsters, adults, seniors, and even animals. Gelteq is extremely complete and versatile, masking each the human and animal markets for nutraceuticals, prescription drugs, and different meals choices.
Are you able to make clear the vital milestones and achievements Gelteq has reached thus far?
Our greatest milestone thus far has been finishing our latest IPO on Nasdaq in October 2024 beneath the ticker GELS. Since finishing the IPO, the corporate has continued to execute on its plans, together with placing 400,000 models into manufacturing and hiring our first US-based government to start our scale-up of U.S. operations. Wholesome Extracts, our largest U.S. buyer, additionally elevated its preliminary buy order of Gelteq collagen and Mynus sugar blocker gels by 50%, citing excessive demand and recognition of the merchandise. The FDA additionally accepted our suitability petition for a brand new animal drug beneath improvement. From a scientific perspective, now we have employed our first Chief Scientific Officer, together with lodging extra scientific patents which permits progress and evolution of the product whereas securing our expertise.
What are the principle challenges the corporate has confronted in bringing its merchandise to market, and the way did you overcome them?
One of many largest challenges we confronted as an organization was having too many product concepts and prioritizing what we may work on. Workers have been getting unfold too skinny and it was limiting the precise merchandise that we have been in a position to full and ship. We’ve got discovered extensively from this and have put in place higher qualification and improvement techniques to handle every venture. We’ve got additionally expanded our staff and positioned individuals on particular verticals and initiatives and given them possession. This new course of has elevated effectivity which enabled extra merchandise to be market-ready and accessible on the market, as proven by the 400,000 models in manufacturing now.
Are you able to talk about your long-term objectives and the place you see Gelteq 5 years from now?
We imagine our gel-based drug supply system is revolutionary within the drug supply area and imagine that is the place we’ll see phenomenal progress within the subsequent 5 years. As FDA approvals are hopefully granted and extra of Gelteq’s gel-based drug merchandise are launched into the market by way of pharmaceutical purchasers, we anticipate there can be a quick shift to undertake our expertise. By fixing the problems of dysphagia and capsule fatigue, Gelteq gives a system that may meet the wants of the individuals impacted. Inside 5 years, we anticipate to see pharmaceutical and veterinarian cabinets having a bit devoted to gel-based drug merchandise, similar to they’ve for tablets, capsules, and gummies.
We may also be frequently engaged on new alternatives and evolving the expertise and imagine that in 5 years, our expertise may have been integrated into many different merchandise extensively accessible throughout the nutraceutical and meals sectors for each people and animals.
What are the upcoming merchandise and improvements Gelteq is presently engaged on?
Gelteq continues to be an innovator within the gel supply area. We’re engaged on new merchandise throughout the nutraceutical, pet, and sports activities verticals, and we’ll proceed to launch a spread of merchandise which are accessible for purchasers to white label and have on cabinets in a matter of months. As this occurs, we’re persevering with to work with shopper requests for creating new gel-based merchandise for his or her present ranges of tablets, capsules, powders, and gummies. Our near-term initiatives are centered on the nutraceutical area, with FDA approvals wanted to drive new pharmaceutical merchandise in our gel base hopefully arriving by late 2025.